Merck & Co., Inc. (NYSE:MRK) is one of the best affordable healthcare stocks to buy now. Jefferies analyst Tycho Peterson reaffirmed a Buy rating on Merck & Co., Inc. (NYSE:MRK) on December 19 and set a $139.00 price target. Why Merck & Co (MRK) Continues to Rank Among the Most Profitable Dividend Stocks The same day, Merck & Co., Inc. (NYSE:MRK) announced a historic agreement with the Trump administration to ensure the affordability and accessibility of its medicines for Americans. The agreement allows ...